Table 3

Treatment within 6 months of diagnosis (n=3855)

Treatment Number %
Any active treatment within 6 months
 Yes218856.8
 No166743.2
Surgery
 Resection41110.7
 Thoracotomy (not resectable)360.9
 No surgery3-150 340888.4
Radiotherapy3-151
 No radiotherapy247464.2
 Radiotherapy to chest ⩾50 Gy3-152 1062.7
 Radiotherapy to chest <50 Gy3-154 107828.0
 Radiotherapy to other sites only1935.0
Chemotherapy3-160
 SCLC (n=678)3-164
  Single agent8712.8
  Combination33749.7
  No chemotherapy25337.3
 NSCLC (n=2071)3-161
  Single agent884.2
  Combination824.0
  No chemotherapy190191.8
 Not known (n=1106)3-163
  Single agent111.0
  Combination151.4
  No chemotherapy108097.6
Entry into clinical trials
 Yes1102.9
 No374597.1

  • ↵3-150 Includes 154 patients who only had a mediastinoscopy.

  • ↵3-151 Four patients received unknown dose of radiotherapy to the chest.

  • ↵3-152 One patient received both radiotherapy to the chest (dose ⩾50 Gy) and radiotherapy to another site.

  • ↵3-154 97 patients received both radiotherapy to the chest (dose <50 Gy) and radiotherapy to another site.

  • ↵3-160 Percentages are of cases with a particular cell type.

  • ↵3-164 One patient with SCLC received chemotherapy but the regimen was not recorded.

  • ↵3-161 Includes cases with a recorded histological type known not to be SCLC.

  • ↵3-163 Includes cases with type not known or not recorded and those with no microscopic verification.